Intuitive Surgical (ISRG) closed at $426.70 on Oct 16, 2026, down 0.3% on the day. The stock is up 11.3% over the past month, up 20.8% over three months, down 24.7% year to date and down 2.0% over the past year. It trades 29.3% below its 52-week high of $603.88 and 29.9% above its 52-week low of $328.57. The close sits above its 50-day moving average ($391.67) and below its 200-day moving average ($439.62).
NextPick tracks ISRG in its Medical Devices basket alongside ABT, MDT, SYK, BSX and BDX. As of Oct 16, 2026, the basket's money-flow score is 15 (weak inflow), and the basket is up 4.5% over five sessions. Over the past month ISRG ranks 1st of 13 basket members by price change.
ISRG is scheduled to report earnings on Oct 20, 2026, after market close. Over its last 8 reports the stock moved an average of 3.6% on the first trading day after earnings, beating the options-implied move in 2 of 8.
ISRG options were pricing 46% at-the-money implied volatility on Oct 8, 2026, an IV rank of 85 over the past year. Form 4 filings over the last 90 days show no open-market purchases and 14 open-market sales by insiders.
ISRG Drops 14% Overnight, Surgical Robot King Falls from His Pedestal?
Earnings exceeded expectations but plunged; the market feared not the present but the slowing surgery volume
Jul 18, 2026
Intuitive Surgical is scheduled to report on Oct 20, 2026, after market close.
Over the last 8 reports, ISRG moved an average of 3.6% on the first trading day after earnings. The move beat the options-implied move in 2 of 8 reports.
No — the Oct 16, 2026 close of $426.70 is 2.9% below the 200-day average of $439.62.
ISRG closed 29.3% below its 52-week high of $603.88.
NextPick groups ISRG with ABT, MDT, SYK, BSX and BDX in its Medical Devices basket.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
